| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.43 Billion | USD 9.38 Billion | 10.60% | 2024 |
FrequentlyAsked Questions
Life science products are tools, instruments, reagents, and consumables that support research, diagnostics, and drug development across pharmaceutical, biotech, healthcare, and academic sectors.
The life science products market is expected to be driven by increasing research and development investments, growing demand for precision medicine applications, technological advancements in laboratory automation and analytics, expansion of biopharmaceutical manufacturing, and rising incidence of chronic and infectious diseases requiring advanced diagnostic solutions.
According to our study, the global life science products market was worth around USD 3.43 billion in 2024 and is predicted to grow to around USD 9.38 billion by 2034.
The CAGR value of the life science products market is expected to be around 10.60% during 2025-2034.
The global life science products market will register the highest growth in North America during the forecast period.
Key players in the life science products market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Holding AG, Illumina, Inc., PerkinElmer Inc., Waters Corporation, Shimadzu Corporation, Bruker Corporation, QIAGEN N.V., Sartorius AG, Eppendorf AG, Mettler-Toledo International Inc., GE Healthcare (now Cytiva), Lonza Group Ltd., Abbott Laboratories, and Siemens Healthineers AG.
The report comprehensively analyzes the life science products market, including an in-depth discussion of market drivers, restraints, emerging technological trends, regional dynamics, and future growth opportunities. It also examines competitive dynamics, innovation pathways, and the evolving research priorities shaping the life science products ecosystem.
HappyClients